420
Participants
Start Date
July 31, 2008
Primary Completion Date
October 30, 2009
Study Completion Date
December 31, 2009
tonapofylline
IV
Placebo
IV
Hus
Sofia
Sofia
Sofia
Sofia
Darlinghurst
Liverpool
Santa Fe
Melbourne
Dandenong
San Miguel de Tucumán
Leipzig
Pazardzhik
Pleven
New York
The Bronx
Mineola
Stony Brook
Safed
Johnson City
Caen
Lahti
Nazareth
Camp Hill
Lancaster
Danville
Doylestown
Philadelphia
Bucharest
Milan
Turku
Baltimore
Bucharest
Nahariya
Bucharest
Danville
Charleston
Concord
Orangeburg
Toulouse
Haifa
Jacksonville
Tampa
Sarasota
Huntsville
Mobile
Nashville
Tullahoma
Oak Ridge
Columbus
Cleveland
Kfar Saba
Franklin
Cincinnati
Mantova
Indianapolis
Muncie
Petah Tikva
Traverse City
Iowa City
Lidköping
Minneapolis
Holon
Tourcoinq
Lombard
Seinäjoki
Frankfurt am Main
St Louis
Lee's Summit
Kansas City
Kansas City
Tel Aviv
Strasbourg
Wichita
Omaha
Beer Yaakov
Fort Smith
Oklahoma City
Oklahoma City
Tulsa
Dallas
Whitney
Houston
San Antonio
Ashkelon
Albi
Beverly Hills
Oulu
Redondo Beach
Torrance
Jerusalem
Jerusalem
Jerusalem
Sylmar
Monterey Park
Chula Vista
Oceanside
San Diego
Mission Viejo
Pontoise
Yuba City
Portland
Tacoma
Olympia
Delhi
New Delhi
Moscow
Moscow
Moscow
Moscow
Moscow
Saint Petersburg
Saint Petersburg
Saint Petersburg
Saint Petersburg
Bikaner
Saratov
Pune
Indore
Bangalore
Bangalore
Chennai
Bacau
Novosibirsk
Novosibirsk
Novosibirsk
Tomsk
Kemerovo
Barnaul
Krasnoyarsk
Thrissur
Hartford
Ayer
Boston
Hyannis
Springfield
West Springfield
Ridgewood
Providence
Buenos Aires
Buenos Aires
Capital Federal
Corrientes
Córdoba
Villa Cabrera
Santa Fe
San Luis
Capital Federal
Canberra
Fortaleza
Porto Alegre
Aracaju
Santo André
São José do Rio Preto
Campo Grande
Curitiba
Porto Alegre
Porto Alegre
Recife
Vancouver
Saint John
Kolín
Uherské Hradiště
Antony
Cholet
Paris
Poitiers
Bad Nauheim
Berlin
Berlin
Bochum
Essen
Frankfurt
Göttingen
Regensburg
Wuppertal
Pavia
Maastricht
The Hague
Zwolle
Kościerzyna
Olsztyn
Słupsk
Tarnów
Warsaw
Warsaw
Wroclaw
Wroclaw
Gothenburg
Lead Sponsor
Biogen
INDUSTRY